Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2524770 | Biomedicine & Pharmacotherapy | 2011 | 13 Pages |
Abstract
Mechanisms underlying tumor growth retarding effect of proton pump inhibitor pantoprazole (PPZ) on a murine T cell lymphoma, designated as Dalton's lymphoma (DL), were investigated. In vivo administration of PPZ to tumor-bearing mice resulted in retardation of tumor progression owing to an inhibition of tumor cell survival and augmented apoptosis. An alteration in the parameters of tumor microenvironment and modulation in the expression of cell growth regulatory molecules is indicated to be involved in PPZ-dependent tumor growth retardation. These findings will help in optimizing therapeutic strategies against cancer using PPZ.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Naveen Kumar Vishvakarma, Sukh Mahendra Singh,